Safety and efficacy of perflubron-induced lung growth in neonates with congenital diaphragmatic hernia: Results of a prospective randomized trial

Keyphrases

• Neonate 100%
• Prospective Randomized Trial 100%
• Lung Growth 100%
• Congenital Diaphragmatic Hernia 100%
• Perflubron 100%
• Early Repair 50%
• Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) 37%
• Lung 25%
• Pulmonary Hypertension 25%
• Exclusion Criteria 12%
• Mechanotransduction 12%
• Ventilation 12%
• Left-handed 12%
• Adverse Events 12%
• Intracranial Hemorrhage 12%
• Continuous Positive Airway Pressure 12%
• Accelerated Growth 12%
• Fetal Lung 12%
• Major Congenital Anomalies 12%
• Air Leak 12%
• Survival to Discharge 12%
• Chest Radiograph 12%
• Institutional Practices 12%
• Midway 12%
• Artificial Ventilation 12%
• Oxygenation Index 12%
• Pulmonary Hypoplasia 12%
• Late Repair 12%
• Anomaly Index 12%

Medicine and Dentistry

• Neonates 100%
• Perflubron 100%
• Congenital Diaphragm Hernia 100%
• Lung 100%
• Extracorporeal Membrane Oxygenation 37%
• Arm 37%
• Pulmonary Hypertension 25%
• Congenital Malformation 12%
• Adverse Event 12%
• Cerebral Hemorrhage 12%
• Thorax Radiography 12%
• Continuous Positive Airway Pressure 12%
• Pulmonary Hypoplasia 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Congenital Diaphragm Hernia 100%
• Perfluorooctyl Bromide 100%
• Pulmonary Hypertension 25%
• Adverse Event 12%
• Brain Hemorrhage 12%
• Congenital Malformation 12%
• Lung Hypoplasia 12%